Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.31 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.31 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15463132 | 0.85 | USP2 (0.52) | USP2LPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL17014615 | 0.85 | USP2 (0.45) | USP2AGTR1LMNACYP1A2 | |
| SCHEMBL26828591 | 0.82 | USP2 (0.48) | USP2LPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL19067465 | 0.81 | USP2 (0.50) | USP2LPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL26153943 | 0.79 | USP2 (0.38) | USP2AGTR1LMNACYP1A2 | |
| SCHEMBL10089439 | 0.78 | USP2 (0.35) | USP2 | |
| SCHEMBL2869714 | 0.77 | USP2 (0.42) | USP2AGTR1LMNACYP1A2 | |
| SCHEMBL16174565 | 0.75 | USP2 (0.39) | USP2LPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL16021363 | 0.75 | USP2 (0.39) | USP2LPAR6LPAR1LPAR4LPAR5 | |
| SCHEMBL15463123 | 0.75 | USP2 (0.48) | USP2LPAR6LPAR1LPAR4LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | MRPL38, ALG8, COG8 | USP2 2452/4885LPAR6 1858/4885LPAR1 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.